"10.1371_journal.pone.0078877","plos one","2013-11-18T00:00:00Z","Jayme L Dahlin; Rondedrick Sinville; Jonathan Solberg; Hui Zhou; Junhong Han; Subhashree Francis; Jessica M Strasser; Kristen John; Derek J Hook; Michael A Walters; Zhiguo Zhang","Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America; Medical Scientist Training Program, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America; Institute for Therapeutics Discovery & Development, University of Minnesota, Minneapolis, Minnesota, United States of America; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America","Conceived and designed the experiments: ZZ DJH JLD RS JS. Performed the experiments: RS JS JLD HZ JH SF KJ JMS. Analyzed the data: JLD RS JS SF DJH MAW ZZ. Contributed reagents/materials/analysis tools: ZZ MAW DJ. Wrote the paper: JLD.","The authors (ZZ, HZ, JH, DH, MAW) have filed a patent titled “Inhibitors of Rtt109 as anti-fungal agents” (WO2012178036 A3) that contains three chemical series identified by the Rtt109 HTS. This will not alter the authors' adherence to the PLOS ONE policies on sharing data and materials.","2013","11","Jayme L Dahlin","JLD",11,TRUE,5,8,7,1,TRUE,TRUE,FALSE,0,NA,FALSE
